Estimate Recalculated Dec 3, 2025 08:04PM EST
New Leaf Ventures II, L.P. has an estimated net worth of $142 Million. This is based on reported shares across multiple companies, which include Principia Biopharma Inc., iRhythm Technologies, Inc., CHIMERIX INC, Oxford Immunotec Global PLC, Neuronetics, Inc., MEI Pharma, Inc., Durata Therapeutics, Inc., Versartis, Inc., ICAGEN INC, and WORLD HEART CORP.
New Leaf Ventures II, L.P.'s CIK is 0001441439
2014 was New Leaf Ventures II, L.P.'s most active year for acquiring shares with 7 total transactions. New Leaf Ventures II, L.P.'s most active month to acquire stocks was the month of February. 2014 was New Leaf Ventures II, L.P.'s most active year for disposing of shares, totalling 13 transactions. New Leaf Ventures II, L.P.'s most active month to dispose stocks was the month of February. 2010 saw New Leaf Ventures II, L.P. paying a total of $16,000,005.90 for 5,848,890 shares, this is the most they've acquired in one year. In 2014 New Leaf Ventures II, L.P. cashed out on 40,588,403 shares for a total of $19,074,752.54, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!